How would you report the application of a biomaterial wound product to a wound that facilitates healing? Should code 15400 (DELETED IN 2012), Xenograft, skin (dermal), for temporary wound closure, trunk, arms, legs; first 100 sq cm or less, or one percent of body area of infants and children, be reported? ...
Subscribe or sign in to view the full article.
Article Overview
This article addresses reporting for biomaterial wound product application in the context of wound care. It is aimed at coders and billing staff who need to distinguish between the wound product itself and any separately reported evaluation, management, or debridement services. The discussion references HCPCS Level II, CPT, and an older deleted code example to clarify the reporting framework at a high level without replacing the full premium guidance.
Why This Topic Matters
Accurate reporting of wound-related services depends on separating the product application from separately billable professional services and using the correct code set for the product. The article helps readers recognize when an outdated code reference is not appropriate and where the relevant coding category belongs.
What You Will Learn
- How biomaterial wound product application is generally reported
- How related evaluation and management services fit into the reporting scenario
- How debridement may be reported alongside the wound product
- Why an older deleted skin-related code is not the correct descriptor in this context
- Which code set is used for the biomaterial wound product versus the service components
Who Should Read This
- Medical coders
- Billing specialists
- Wound care staff
- Revenue cycle professionals
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com